Literature DB >> 28853253

[Establishment of a high sensitive indirect ELISA for detecting specific antibodies against H9 subtype avian influenza virus].

Wei Zhang1,2, Lidan Hou3, Jie Song1,2, Shuang Zhang1, Yun Li1, Jing Li1, Lei Sun1,2, Wenhui Fan1, Wenjun Liu1,2.   

Abstract

H9 subtype avian influenza virus causes worldwide epidemic, resulting in enormous economic losses of poultry production. In the present study, an indirect ELISA method was established for more accurate and specific detection. The recombinant protein of the globular head domain of HA of H9 subtype avian influenza virus was used as antigen. Specific blocking buffers and dilution buffers were determined to increase the sensitivity and specificity. The sensitivity of ELISA was higher than that of hemagglutination inhibition (HI) test. The coating antigen is very specific and no cross-reactivity with positive serum against H3N2, H5N2 and H7N9 subtype influenza viruses, Newcastle disease virus, avian infectious bronchitis virus, avian infectious disease virus, and egg drop syndrome virus. Two hundred of clinical sera samples were examined. The results indicate the coincidence rate between ELISA and HI test reached 97%. In addition, there was a positive correlation between OD450 values and the logarithm of HI titer to the base 2 of an individual serum sample (R2=0.981 1).

Entities:  

Keywords:  H9 subtype; avian influenza virus; hemagglutination inhibition test; hemagglutinin; indirect ELISA

Mesh:

Substances:

Year:  2017        PMID: 28853253     DOI: 10.13345/j.cjb.160483

Source DB:  PubMed          Journal:  Sheng Wu Gong Cheng Xue Bao        ISSN: 1000-3061


  1 in total

1.  An improved luciferase immunosorbent assay for ultrasensitive detection of antibodies against African swine fever virus.

Authors:  Qiongjie Wang; Zhancheng Tian; Jifei Yang; Shandian Gao; Junzheng Du; Hongge Zhang; Zhonghui Zhang; Guiquan Guan; Qingli Niu; Hong Yin
Journal:  Front Microbiol       Date:  2022-09-29       Impact factor: 6.064

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.